1999 (Cycle V)
Innovative Awards: IDEA (Innovative, Developmental, and Exploratory Awards) Top
| Postmenopausal Breast Cancer: Obesity & the Leptin Receptor | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Hormones & nutrition | ||||
| Award Type: IDEA | ||||
| Breast Cancer Susceptibility Genes in Very High Risk Women | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: IDEA | ||||
| Exercise, Hormones and Breast Cancer Prevention | ||||
| University of Southern California | ||||
| Research Priority: Prevention & Risk Reduction > Active lifestyle modification | ||||
| Award Type: IDEA | ||||
| Id-1 Expression During Breast Cancer Progression | ||||
| California Pacific Medical Center Research Institute | ||||
| Research Priority: Pathogenesis > Unraveling the path to breast cancer | ||||
| Award Type: IDEA | ||||
| Identification of Novel Secreted Proteins of Breast Cancer | ||||
| Cedars-Sinai Medical Center | ||||
| Research Priority: Imaging, Biomarkers, & Molecular Pathology > Biomarkers & novel screening | ||||
| Award Type: IDEA | ||||
| Role of Chemokine Receptors in Breast Cancer Metastasis | ||||
| University of California, Los Angeles | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: IDEA | ||||
| Novel Breast Cancer Anti-Angiogenic Compounds | ||||
| University of California, Los Angeles | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: IDEA | ||||
| Impact of Opioid Peptides on Breast Cancer Etiology | ||||
| Lawrence Livermore National Laboratory | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: IDEA | ||||
Collaboration Awards: CRC (Community Research Collaboration) Full Research Awards Top
| Marin County Breast Cancer Study of Adolescent Risk Factors | ||||
| Marin Breast Cancer Watch | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: CRC Full | ||||
| Marin County Breast Cancer Study of Adolescent Risk Factors | ||||
| University of California, San Francisco | ||||
| Research Priority: Etiology > Other searches for the causes | ||||
| Award Type: CRC Full | ||||
Career Development Awards: Postdoctoral Fellowship Top
| Role of a DNA Damage Response Gene in Breast Cancer | ||||
| California Institute of Technology | ||||
| Research Priority: Pathogenesis > Searching the unknown | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Hox Genes in Normal Breast Development and Breast Cancer | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Biology of the Normal Breast > Breast development | ||||
| Award Type: Postdoctoral Fellowship | ||||
| SXR: A Novel Target for Breast Cancer Therapeutics | ||||
| University of California, Irvine | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Cloning of Senescence Genes in Mammary Epithelial Cells | ||||
| Stanford University | ||||
| Research Priority: Biology of the Normal Breast > Breast aging | ||||
| Award Type: Postdoctoral Fellowship | ||||
| COX-2 and Apoptosis Regulation in Breast Cancer | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: Postdoctoral Fellowship | ||||
| The Shp-2 Tyrosine Phosphatase in Breast Tumor Migration | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Proteolysis of Cyclin E in Normal and Malignant Breast Cells | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Unraveling the path to breast cancer | ||||
| Award Type: Postdoctoral Fellowship | ||||
| ACTR/A1B1 in Mammary Gland Development and Tumorigenesis | ||||
| Salk Institute for Biological Studies | ||||
| Research Priority: Biology of the Normal Breast > Breast development | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Mechanism of Radiosensitivity in Breast Cancer Cells | ||||
| Scripps Research Institute | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Bispecific Antibodies for Radiotherapy of Breast Cancer | ||||
| University of California, Davis | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: Postdoctoral Fellowship | ||||
Collaboration Awards: TRC (Translational Research Collaboration) Full Research Awards Top
| Can Molecular Markers Predict Response to Adjuvant Therapy | ||||
| Kaiser Foundation Research Institute | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: TRC Full | ||||
| Can Molecular Markers Predict Response to Adjuvant Therapy? | ||||
| University of Southern California | ||||
| Research Priority: Innovative Treatments > Immune therapy | ||||
| Award Type: TRC Full | ||||
Career Development Awards: Training Program Top
Collaboration Awards: CRC (Community Research Collaboration) Pilot Awards Top
Innovative Awards: IDEAS II Top
| GATA-3 Expression in Hormone Responsive Breast Cancer | ||||
| Stanford University | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: IDEAS II | ||||
| Nitric Oxide and Arginine in Normal and Tumorous Breast | ||||
| University of California, San Diego | ||||
| Research Priority: Biology of the Normal Breast > Breast function | ||||
| Award Type: IDEAS II | ||||
| Unique Genes Expressed in Cancer Cells | ||||
| University of California, Riverside | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: IDEAS II | ||||
| IGF System and Breast Cancer in Postmenopausal Women | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: IDEAS II | ||||
| Breast Cancer Prevention by Inhibition of Estrogen Action | ||||
| Cedars-Sinai Medical Center | ||||
| Research Priority: Prevention & Risk Reduction > Other searches for the causes | ||||
| Award Type: IDEAS II | ||||
| Oncogenes, Progression and Biomarkers | ||||
| University of California, Davis | ||||
| Research Priority: Imaging, Biomarkers, & Molecular Pathology > Biomarkers & novel screening | ||||
| Award Type: IDEAS II | ||||
| HER2/Neu DNA Vaccines for Breast Cancer | ||||
| University of California, San Francisco | ||||
| Research Priority: Innovative Treatments > Immune therapy | ||||
| Award Type: IDEAS II | ||||
| Breast Cancer Cell Binding to the Endothelium | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: IDEAS II | ||||
| Indole Derivatives as Novel Breast Cancer Therapeutics | ||||
| University of California, Berkeley | ||||
| Research Priority: Innovative Treatments > Hormone and chemotherapy targets | ||||
| Award Type: IDEAS II | ||||
| The Regulation of p53 Activity in Breast Cancer | ||||
| University of California, San Diego | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: IDEAS II | ||||
| Role of the POP1 Gene in Breast Cancer Genomic Stability | ||||
| Stanford University | ||||
| Research Priority: Biology of the Normal Breast > Breast function | ||||
| Award Type: IDEAS II | ||||
| Molecular Structure of BAG-1:a New Protein in Breast Cancer | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Searching the unknown | ||||
| Award Type: IDEAS II | ||||
| How Does Endostatin Inhibit Breast Cancer Angiogenesis? | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: IDEAS II | ||||
| Targeting Breast Cancer Blood Vessels | ||||
| Sidney Kimmel Cancer Center | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: IDEAS II | ||||
| Clinical Utility of Breast Cancer DNA Markers in Plasma | ||||
| John Wayne Cancer Institute | ||||
| Research Priority: Imaging, Biomarkers, & Molecular Pathology > Biomarkers & novel screening | ||||
| Award Type: IDEAS II | ||||
| Mechanisms of Fluid Transport in Human Mammary Epithelium | ||||
| University of California, Berkeley | ||||
| Research Priority: Biology of the Normal Breast > Breast function | ||||
| Award Type: IDEAS II | ||||
| Role of the EphB4 Receptor Tyrosine Kinase in Breast Cancer | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: IDEAS II | ||||
| New Radiation Therapy for HER-2-overexpressing Breast Cancer | ||||
| University of California, Los Angeles | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: IDEAS II | ||||
| A New Gene Regulation Factor, LMO-4, in Breast Cancer | ||||
| University of California, San Diego | ||||
| Research Priority: Pathogenesis > Mistakes on the master blueprint | ||||
| Award Type: IDEAS II | ||||
| Breast Cancer Gene Expression Using Amplified Core Biopsies | ||||
| Stanford University | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: IDEAS II | ||||
| A New Model for Inflammatory Breast Carcinoma | ||||
| University of California, Los Angeles | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: IDEAS II | ||||
| Specificity of Ras Signaling in Breast Cancer | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: IDEAS II | ||||
| Spatial Control of Matrix Proteolysis in Breast Cancer | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: IDEAS II | ||||
| Laboratory Testing of Chinese Herbs Used for Breast Cancer | ||||
| University of California, San Francisco | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: IDEAS II | ||||
| A New Gene Regulation Factor, LMO-4, in Breast Cancer | ||||
| University of California, Irvine | ||||
| Research Priority: Pathogenesis > Mistakes on the master blueprint | ||||
| Award Type: IDEAS II | ||||
| Spatial Control of Matrix Proteolysis in Breast Cancer | ||||
| La Jolla Institute for Molecular Medicine | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: IDEAS II | ||||
Topic-targeted Research Awards: RFA (Request for Applications) Top
| Estrogen metabolizing genes, soy and breast cancer in Asians | ||||
| University of Southern California | ||||
| Research Priority: Prevention & Risk Reduction > Other searches for the causes | ||||
| Award Type: RFA | ||||
Career Development Awards: New Investigator Top
| Characterization of hAG-2 and Its Role in Breast Cancer | ||||
| Stanford University | ||||
| Research Priority: Pathogenesis > Searching the unknown | ||||
| Award Type: New Investigator | ||||
| A Role for RAD51B in Breast Cancer | ||||
| Lawrence Livermore National Laboratory | ||||
| Research Priority: Pathogenesis > Mistakes on the master blueprint | ||||
| Award Type: New Investigator | ||||
